Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Oncology
Michael GnantAustrian Breast and Colorectal Cancer Study Group

Abstract

In postmenopausal women with hormone receptor-positive, early-stage breast cancer, treatment with adjuvant aromatase inhibitors is the standard of care, but it increases risk for osteoporosis and fractures. Results from the ABCSG-18 trial showed that use of denosumab as an adjuvant to aromatase inhibitor therapy significantly reduced clinical fractures. Disease-free survival outcomes from ABCSG-18 have not yet been reported. Postmenopausal patients with early, hormone receptor-positive, non-metastatic adenocarcinoma of the breast, who had completed their initial adjuvant treatment pathway (surgery, radiotherapy, or chemotherapy, or a combination) and were receiving adjuvant aromatase inhibitors, were enrolled at 58 trial centres in Austria and Sweden into this prospective, double-blind, placebo-controlled, phase 3 trial. With permuted block randomisation (block sizes 2 and 4, stratified by previous aromatase inhibitor use, total lumbar spine bone mineral density score at baseline, and type of centre), patients were assigned (1:1) to receive subcutaneous denosumab (60 mg) or matching placebo every 6 months during aromatase inhibitor therapy. The primary endpoint (previously reported) was the time to first clinical fracture after...Continue Reading

Citations

Sep 25, 2019·Nature Reviews. Disease Primers·Nadia HarbeckFatima Cardoso
Mar 4, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Edna Cheung, Hala T Borno
Mar 10, 2020·Japanese Journal of Clinical Oncology·Tadahiko Shien, Hiroji Iwata
Jul 14, 2020·Expert Opinion on Biological Therapy·Maria V Deligiorgi, Dimitrios T Trafalis
Jul 17, 2020·The Journal of Clinical Endocrinology and Metabolism·Tilman D RachnerLorenz C Hofbauer
Nov 7, 2019·Journal of the National Cancer Institute·Julie R GralowGabriel N Hortobagyi
Dec 20, 2019·Hormones : International Journal of Endocrinology and Metabolism·Stavroula A PaschouIrene Lambrinoudaki
Aug 28, 2020·Frontiers in Oncology·Jie MingJosef M Penninger
Aug 8, 2020·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Rachelle W Johnson
Jan 4, 2020·JAMA Network Open·Vasily Giannakeas
Dec 22, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yoshitaka AraseAtsushi Tanaka
Apr 30, 2020·International Journal of Molecular Sciences·Stella D'OronzoMarco Tucci
Mar 7, 2019·Nature Reviews. Clinical Oncology·Diana Romero
Mar 4, 2020·Breast Cancer Research and Treatment·Irene E G van HellemondUNKNOWN Dutch Breast Cancer Research Group (BOOG)
Jun 20, 2020·Nature Reviews. Clinical Oncology·Nora PashayanMartin Widschwendter
Jun 26, 2020·Frontiers in Oncology·Michele IulianiDaniele Santini
Jul 13, 2019·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Jonatan DewulfPhilippe Clézardin
Oct 6, 2020·Current Oncology Reports·Elaine M WalshCesar A Santa-Maria
Nov 5, 2020·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H R SapkotaS Venkatachalam
Nov 19, 2020·International Journal of Molecular Sciences·Alisson ClemenceauFrancine Durocher
Dec 9, 2020·Expert Opinion on Drug Safety·Maria V Deligiorgi, Dimitrios T Trafalis
Jan 3, 2021·Journal of Bone and Mineral Metabolism·Kazuo Okamoto
Aug 3, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael Gnant
Sep 10, 2019·Journal of Bone Oncology·Matthew LockwoodIssam Makhoul
Oct 17, 2020·Nature Reviews. Disease Primers·Robert E ColemanLuis Costa
Nov 10, 2020·Frontiers in Endocrinology·Manuel A RiquelmeJean X Jiang
Dec 12, 2020·Nature Communications·Clara Gómez-AlezaEva González-Suárez
Mar 16, 2021·Current Osteoporosis Reports·Courtney M Edwards, Rachelle W Johnson
Jun 18, 2020·Seminars in Oncology·Elaine M WalshVered Stearns
Jul 13, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Merav BarPaul A Carpenter
Apr 5, 2021·Lancet·Sibylle LoiblGiuseppe Curigliano
Apr 13, 2021·Oncology & Hematology Review·Kristy A BrownPanagiota Andreopoulou
Apr 21, 2021·Nature Reviews. Clinical Oncology·Lorenz C HofbauerKlaus Pantel
Sep 30, 2020·Hormone Molecular Biology and Clinical Investigation·Christian F Singer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.